Accelerating Drug Development with Advanced Modeling and Analytics

Certara is a leading provider of software and tech-enabled services for drug discovery and development. The company offers biosimulation, data science, regulatory, market access, discovery informatics, and AI solutions to inform key decisions throughout the drug development process. Certara's quantitative approach provides unique insights to anticipate risks and guide strategies. This removes uncertainty and builds confidence in development programs. Certara's decades of experience, proprietary biosimulation software, and tech-enabled services deliver the knowledge to accelerate regulatory and commercial success. The company's software includes Phoenix for pharmacokinetic/pharmacodynamic analysis, Simcyp for physiologically based pharmacokinetic modeling, Pinnacle 21 for regulatory data management, and D360 for discovery informatics. Certara has helped over 2000 customers globally redefine what's possible for modern medicine through modeling, simulation, and data-driven decision support.

The company's 900+ scientists and domain experts partner with customers across all major therapeutic areas and regions worldwide.